Results 141 to 150 of about 1,255,934 (217)

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry. [PDF]

BMC Cardiovasc Disord, 2023
Kang J, Han JK, Yang HM, Park KW, Kang HJ, Koo BK, Choo EH, Lee JY, Park SD, Lim YH, Kim HM, Heo JH, Kim HS.   +12 more
europepmc   +1 more source

Letter to the Editor regarding: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI". [PDF]

Cardiol J
Umińska JM.
europepmc   +1 more source

Response to the response to the letter: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab". [PDF]

Cardiol J
Umińska JM.
europepmc   +1 more source

Knockout of P2Y12 receptor facilitates neuronal envelopment by reactive microglia and accelerates prion disease. [PDF]

J Neuroinflammation
Makarava N, Safadi T, Bocharova O, Mychko O, Pandit NP, Molesworth K, Eyo UB, Baskakov IV.   +7 more
europepmc   +1 more source

GP IIb/IIIa Receptor Inhibitors in Mechanically Ventilated Patients with Cardiogenic Shock due to Myocardial Infarction in the Era of Potent P2Y12 Receptor Antagonists. [PDF]

J Clin Med, 2022
Kanic V, Kompara G, Suran D.
europepmc   +1 more source

The Extended Safety and Efficacy of Indobufen in Conjunction With P2Y12 Receptor Inhibitors Among Patients Undergoing Revascularization: A Meta-Analysis and Overview. [PDF]

Cardiovasc Ther
Yi M, Cao Q, Sheng YH, Wu L, Ke X.
europepmc   +1 more source

Design, Synthesis and Preclinical Evaluation of a Brain-Permeable PET Tracer for P2Y12 Receptor Imaging in the Brain. [PDF]

J Med Chem
Joseph E, Kunze LH, Schaefer R, Palumbo G, Kugelmann B, Wagner S, Lammich S, Feederle R, Willem M, Werner RA, Brendel M, Lindner S.   +11 more
europepmc   +1 more source

Correction to: Role and recent progress of P2Y12 receptor in cancer development. [PDF]

Purinergic Signal
Xi Y, Min Z, Liu M, Lin X, Yuan ZH.
europepmc   +1 more source

The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction. [PDF]

Korean J Intern Med, 2022
Park KH, Jeong MH, Kim HK, Ki YJ, Kim SS, Ahn Y, Kook HY, Kim HS, Gwon HC, Seung KB, Rha SW, Chae SC, Kim CJ, Cha KS, Park JS, Yoon JH, Chae JK, Joo SJ, Choi DJ, Hur SH, Seong IW, Cho MC, Kim DI, Oh SK, Ahn TH, Hwang JY, KAMIR-NIH registry investigators.   +26 more
europepmc   +1 more source

Platelet reactivity when switching from cangrelor to oral P2Y12 receptor inhibitors: insights from a real-world registry. [PDF]

EuroIntervention
Franchi F, Laudani C.
europepmc   +1 more source